FLG and Alzheimer disease: The deficiency of filaggrin in AD patients contribute to an impaired skin barrier function of the epidermis, which subsequently increases trans-epidermal water loss, pH alterations, and the risk for microbial infection or development of other atopic diseases (Cabanillas and Novak, 2016).